Mounjaro®
Starting from £179.99/mo
Start journey Learn moreOnce a Mounjaro KwikPen has been removed from the fridge, it can be kept at room temperature for a maximum of 30 days. After that point, the pen should not be used, even if doses remain and the liquid looks unchanged. This is the limit set out in the Mounjaro Patient Information Leaflet and the Summary of Product Characteristics published on the Electronic Medicines Compendium (eMC). Tirzepatide is a prescription-only medicine, and every decision about your treatment — including what to do if you have missed doses or are unsure about a pen's storage history — should be made with your prescribing clinician.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
A question our prescribers hear most weeks is whether the 30 days begins at the first injection or the moment the pen is taken out of the fridge. The answer is the latter. As soon as the pen is removed from refrigerated storage, the countdown begins, even if you put it back in the fridge the same afternoon and used it from the fridge again the following week. That brief spell at room temperature counts toward your total. The Mounjaro SmPC on the eMC is the authoritative reference for these conditions, and your Patient Information Leaflet carries the same guidance in plain language.
Before that first removal, the pen is stable in the fridge at 2–8°C for the full shelf life shown on the label. Many people find it easiest to keep all unused pens refrigerated and only bring one out when they are ready to use it. If you would like a practical walkthrough of using your Mounjaro pen after 30 days have elapsed, including what the guidance means for your routine, that page sets out the detail clearly.
For a fuller look at what the storage rules mean in practice, the page on Mounjaro storage after 30 days in the fridge covers the question in detail.
Time is only half the picture. The pen must also be kept below 30°C throughout its time out of the fridge. On a warm summer day, a pen left on a windowsill, in a car glovebox, or near a radiator could reach that threshold well before 30 days have passed. If there is any reason to think the pen has been exposed to heat above that limit, you should not use it, contact your prescriber or pharmacist for advice before proceeding.
This matters because protein-based medicines like tirzepatide can degrade when exposed to heat, and that degradation is not always visible. The liquid may still look clear and colourless even if potency has been affected. This is exactly why the storage limits in the SmPC exist: they reflect stability data from controlled testing, not a conservative guess. The NHS medicines page for tirzepatide also points readers to the leaflet for storage detail, reinforcing that these instructions are non-negotiable.
If you are travelling or carrying your pen during the day, a cool bag or insulated pouch keeps the temperature stable. Avoid storing it in direct sunlight or in a hot car.
If you realise your pen has been out of the fridge for more than 30 days, do not use it. Even if doses remain, the storage window has closed and the medicine should be treated as expired. Continuing to inject from a pen that has exceeded its room-temperature limit carries an unknown risk: the dose you receive may be lower than intended, and the clinical outcome will not match what your prescriber planned for you.
Dispose of the pen in a sharps container and contact your provider to discuss a replacement. If you are managing your treatment through nume, our prescribers are available seven days a week to advise on the next step, including whether a dose needs to be reconsidered in light of a missed or voided injection.
For related detail on what actually happens if the pen is used beyond this point, the page on using Mounjaro after 30 days covers the clinical reasoning. And if you are thinking about how to plan ahead so this situation does not arise again, the overview of how the Mounjaro injection works is a useful starting point alongside your leaflet.
The simplest approach is to write the removal date on the pen with a marker the moment it comes out of the fridge. Thirty days from that date is your hard deadline. If your weekly injections fall on the same day each week, a pen containing four doses should be used up in about 28 days from first removal, giving you a small buffer before the limit arrives.
Some people on a treatment programme manage more than one pen at once, perhaps because they receive a month's supply. Keep any pen you are not yet using in the fridge until the previous one is finished. This also means that if your schedule shifts (a holiday, an illness, a delayed injection) the spare pen's clock has not yet started. The page on what to do with your Mounjaro pen after injection explains the needle and recap steps that form the routine around each dose.
Mounjaro is a prescription medicine for weight management, available through a registered pharmacy following a clinical assessment. If you are not yet on treatment and want to understand the full process (including eligibility and what a private prescription involves) our treatment consultation page is the right place to start. You can also read a broader overview of Mounjaro for weight loss in the UK or explore weight-loss treatment options more generally.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.